Pine River Capital Management’s AbbVie ABBV Stock Holding History

Pine River Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-82,639	Closed	-$4.89M	–	640
2015 Q4	$4.89M	Sell	82,639 -303,165	-79%	-$17.5M	0.07%	199
2015 Q3	$21M	Buy	385,804 +66,452	+21%	+$4.33M	0.27%	68
2015 Q2	$21.5M	Buy	319,352 +2,973	+0.9%	+$194K	0.23%	91
2015 Q1	$18.5M	Buy	+316,379	New	+$19.1M	0.23%	91
2014 Q3	–	Sell	-324,114	Closed	-$18M	–	961
2014 Q2	$18.3M	Buy	+324,114	New	+$17M	0.28%	77

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Pine River Capital Management's ABBV Position: Q1 2016 in Review

Pine River Capital Management sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 82,639 shares — an estimated $4.89M sold.

Pine River Capital Management first reported a position in ABBV in Q2 2014 and held it in 5 quarters. The position peaked at $21.5M in Q2 2015. 1,640 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Pine River Capital Management reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
Pine River Capital Management sold 82,639 AbbVie shares in Q1 2016, an estimated $4.89M.
Pine River Capital Management first reported a position in AbbVie in Q2 2014 and held it in 5 quarters.
Pine River Capital Management's AbbVie position peaked at $21.5M in Q2 2015.
1,640 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Pine River Capital Management's 13F filing for Q1 2016, filed 16 May 2016.